Serveur d'exploration sur la maladie de Parkinson - Curation (Accueil)

Index « ISSN » - entrée « Synapse »
Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.
Surg Today < Synapse < TICS  Facettes :

List of bibliographic references

Number of relevant bibliographic references: 29.
[0-20] [0 - 20][0 - 29][20-28][20-40]
Ident.Authors (with country if any)Title
000420 (2003) Elina Nurmi [Finlande] ; Jörgen Bergman [Finlande] ; Olli Eskola [Finlande] ; Olof Solin [Finlande] ; Tero Vahlberg [Finlande] ; Pirkko Sonninen [Finlande] ; Juha O. Rinne [Finlande]Progression of dopaminergic hypofunction in striatal subregions in Parkinson's disease using [18F]CFT PET
000476 (1998) C. S. Biggs [Royaume-Uni] ; A. Fisher [Royaume-Uni] ; M. S. Starr [Royaume-Uni]The antiparkinsonian drug budipine stimulates the activity of aromatic L‐amino acid decarboxylase and enhances L‐DOPA‐induced dopamine release in rat substantia nigra
000791 (1999) C. S. Biggs [Royaume-Uni] ; M. S. Starr [Royaume-Uni]Microdialysis study of the effects of the antiparkinsonian drug budipine on L‐DOPA‐induced release of dopamine and 5‐hydroxytryptamine by rat substantia nigra and corpus striatum
000810 (1993) Philip Seeman [Canada] ; Hong-Chang Guan [Canada] ; Hubert H. M. Van Tol [Canada] ; Hyman B. Niznik [Canada]Low density of dopamine D4 receptors in Parkinson's, schizophrenia, and control brain striata
000C48 (2003) Raúl De La Fuente-Fernández [Canada] ; Andrew S. Lim [Canada] ; Vesna Sossi [Canada] ; Michael J. Adam [Canada] ; Thomas J. Ruth [Canada] ; Donald B. Calne [Canada] ; A. Jon Stoessl [Canada] ; Chong S. Lee [Canada]Age and severity of nigrostriatal damage at onset of Parkinson's disease
000F49 (2001) Alan J. Fischman [États-Unis] ; Ali A. Bonab [États-Unis] ; John W. Babich [États-Unis] ; E. Livni [États-Unis] ; Nathaniel M. Alpert [États-Unis] ; Peter C. Meltzer [États-Unis] ; Bertha K. Madras [États-Unis][11C,127I] Altropane: A highly selective ligand for PET imaging of dopamine transporter sites
001023 (2000) Sophie Callier [Canada, France] ; Marc Morissette [Canada] ; Michelle Grbois [Canada] ; Thérèse Di Paolo [Canada]Stereospecific prevention by 17β‐estradiol of MPTP‐induced dopamine depletion in mice
001172 (2008) Anna R. Carta [Italie] ; Frau Lucia [Italie] ; Pinna Annalisa [Italie] ; Pontis Silvia [Italie] ; Simola Nicola [Italie] ; Schintu Nicoletta [Italie] ; Morelli Micaela [Italie]Behavioral and biochemical correlates of the dyskinetic potential of dopaminergic agonists in the 6‐OHDA lesioned rat
001403 (2000) Arpesh Mehta [États-Unis] ; Kyriaki Thermos [Grèce] ; Marie-Françoise Chesselet [États-Unis]Increased behavioral response to dopaminergic stimulation of the subthalamic nucleus after nigrostriatal lesions
001532 (2011) Lucia Frau [Italie] ; Franco Borsini [Italie] ; Jadwiga Wardas [Pologne] ; Amit S. Khairnar [Italie] ; Nicoletta Schintu [Italie] ; Micaela Morelli [Italie]Neuroprotective and anti‐inflammatory effects of the adenosine A2A receptor antagonist ST1535 in a MPTP mouse model of Parkinson's disease
001704 (2001) Juha O. Rinne [Finlande] ; Elina Nurmi [Finlande] ; Hanna M. Ruottinen [Finlande] ; Jörgen Bergman [Finlande] ; Olli Eskola [Finlande] ; Olof Solin [Finlande][18F]FDOPA and [18F]CFT are both sensitive PET markers to detect presynaptic dopaminergic hypofunction in early Parkinson's disease
001825 (2009) Zhen Qi [États-Unis] ; Gary W. Miller [États-Unis] ; Eberhard O. Voit [États-Unis]Computational analysis of determinants of dopamine (DA) dysfunction in DA nerve terminals
001C98 (1991) Christian Waeber [Suisse] ; Monique Rigo [Suisse] ; Giorgia Chinaglia [Suisse] ; Alphonse Probst [Suisse] ; José M. Palacios [Suisse]Beta‐adrenergic receptor subtypes in the basal ganglia of patients with Huntington's chorea and Parkinson's disease
001E75 (2009) Shin-Ichi Muramatsu [Japon] ; Tsuyoshi Okuno [Japon] ; Yutaka Suzuki [Japon] ; Takashi Nakayama [Japon] ; Takeharu Kakiuchi [Japon] ; Naomi Takino [Japon] ; Asako Iida [Japon] ; Fumiko Ono [Japon] ; Keiji Terao [Japon] ; Nobuo Inoue [Japon] ; Imaharu Nakano [Japon] ; Yasushi Kondo [Japon] ; Hideo Tsukada [Japon]Multitracer assessment of dopamine function after transplantation of embryonic stem cell‐derived neural stem cells in a primate model of Parkinson's disease
001E95 (1999) Yasushi Ito [Japon] ; Masahiro Fujita [Japon] ; Shoichi Shimada ; Yoshiyuki Watanabe [Japon] ; Tomoya Okada [Japon] ; Hideo Kusuoka [Japon] ; Masaya Tohyama [Japon] ; Tsunehiko Nishimura [Japon]Comparison between the decrease of dopamine transporter and that of L‐DOPA uptake for detection of early to advanced stage of Parkinson's disease in animal models
001F46 (1995) Juha O. Rinne [Finlande] ; Arto Laihinen [Finlande] ; Kjell N Gren [Finlande] ; Hanna Ruottinen [Finlande] ; Ulla Ruotsawnen [Finlande] ; Urpo K. Rinne [Finlande]PET examination of the monoamine transporter with [11c]β‐CIT and [11c]β‐CFT in early parkinson's disease
002005 (2000) J. M. Van Kampen [Canada] ; E. G. Mcgeer [Canada] ; A. Jon Stoessl [Canada]Dopamine transporter function assessed by antisense knockdown in the rat: Protection from dopamine neurotoxicity
002065 (2007) Annalisa Pinna [Italie] ; Silvia Pontis [Italie] ; Franco Borsini [Italie] ; Micaela Morelli [Italie]Adenosine A2A receptor antagonists improve deficits in initiation of movement and sensory motor integration in the unilateral 6‐hydroxydopamine rat model of Parkinson's disease
002568 (1997) Jean-Paul Soucy [Canada] ; Abdelghani Mrini [Canada] ; Francine Lafaille [Canada] ; Guy Doucet [Canada] ; Laurent Descarries [Canada]Comparative evaluation of [3H]WIN 35428 and [3H]GBR 12935 as markers of dopamine innervation density in brain
002633 (1999) Martin Goulet ; Marc Morissette ; Richard Grondin ; Pierre Falardeau ; Paul J. Bédard ; William Rostène [France] ; Thérèse Di PaoloNeurotensin receptors and dopamine transporters: Effects of MPTP lesioning and chronic dopaminergic treatments in monkeys
002802 (2010) Kevin St. P. Mcnaught [États-Unis] ; Ruth Jnobaptiste [États-Unis] ; Tehone Jackson [États-Unis] ; Toni-Ann Jengelley [États-Unis]The pattern of neuronal loss and survival may reflect differential expression of proteasome activators in Parkinson's disease

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Wicri/Sante/explor/ParkinsonV1/Data/Main/Curation
HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Curation/ISSN.i -k "Synapse" 
HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Curation/ISSN.i  \
                -Sk "Synapse" \
         | HfdSelect -Kh $EXPLOR_AREA/Data/Main/Curation/biblio.hfd 

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Wicri/Sante
   |area=    ParkinsonV1
   |flux=    Main
   |étape=   Curation
   |type=    indexItem
   |index=    ISSN.i
   |clé=    Synapse
}}

Wicri

This area was generated with Dilib version V0.6.23.
Data generation: Sun Jul 3 18:06:51 2016. Site generation: Wed Mar 6 18:46:03 2024